Published in Life Sci on January 01, 1994
Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A (2003) 1.79
Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging. Brain Res Bull (2007) 1.00
Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology (Berl) (2005) 0.91
A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease. PLoS One (2013) 0.90
Modeling Alzheimer's disease with non-transgenic rat models. Alzheimers Res Ther (2013) 0.84
Effects of chronic adult dietary restriction on spatial learning in the aged F344 x BN hybrid F1 rat. Physiol Behav (2007) 0.79
Network analysis of exploratory behaviors of mice in a spatial learning and memory task. PLoS One (2017) 0.75
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
Gender-linked brain injury in experimental stroke. Stroke (1998) 3.08
Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (1988) 3.01
Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia (2000) 2.82
Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75
Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience (2009) 2.38
Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67
Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem (2001) 1.66
Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology (2001) 1.61
17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke (1999) 1.58
A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem (2001) 1.58
Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology (2000) 1.56
Element-selective single atom imaging. Science (2000) 1.53
The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48
Dietary restriction benefits learning and motor performance of aged mice. J Gerontol (1987) 1.48
Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain. Anesthesiology (1989) 1.47
Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 1.46
Nucleotide sequence of the malate dehydrogenase gene of Thermus flavus and its mutation directing an increase in enzyme activity. J Biol Chem (1986) 1.42
Development and pilot-testing of a psoriasis screening tool. Br J Dermatol (2009) 1.41
Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41
The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 1.38
Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia. J Bacteriol (1999) 1.32
Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development. Proc Natl Acad Sci U S A (2001) 1.32
Human IgGFc binding protein (FcgammaBP) in colonic epithelial cells exhibits mucin-like structure. J Biol Chem (1997) 1.31
The smallest carbon nanotube. Nature (2000) 1.31
Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA (1969) 1.30
Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem (1997) 1.28
Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry (2008) 1.25
In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chem Biol Interact (2005) 1.24
Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids. Gut (2002) 1.22
Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21
Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest (1997) 1.20
Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20
Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin Sci (Lond) (1995) 1.14
Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus (2001) 1.12
Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain (1983) 1.08
Why so few drugs for Alzheimer's disease? Are methods failing drugs? Curr Alzheimer Res (2010) 1.08
Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08
Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function. Neurobiol Aging (2000) 1.07
IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr J (1999) 1.06
One-dimensional metallofullerene crystal generated inside single-walled carbon nanotubes. Phys Rev Lett (2000) 1.05
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry (2007) 1.05
2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem (1998) 1.04
Production of transgenic quails with high frequency of germ-line transmission using VSV-G pseudotyped retroviral vector. Biochem Biophys Res Commun (2001) 1.04
Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience (1991) 1.04
Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus. Microbiol Immunol (1981) 1.04
Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res (1990) 1.03
Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev Med Chem (2009) 1.03
Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol (1985) 1.02
Expression of chromatin remodeling factors during neural differentiation. J Biochem (2001) 1.01
Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry (2008) 1.01
Structure and function of a novel coliphage-associated sialidase. FEMS Microbiol Lett (2000) 0.99
Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience (1994) 0.99
Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke (1998) 0.98
Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98
Differential effects of age on motor performance in two mouse strains. Neurobiol Aging (1981) 0.98
Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. J Med Chem (1999) 0.98
2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol (1998) 0.98
Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci (1997) 0.97
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans. Drug Metab Dispos (2000) 0.97
Acetyl-1-carnitine. 2: Effects on learning and memory performance of aged rats in simple and complex mazes. Neurobiol Aging (1990) 0.97
Livebirth prevalence and follow-up of malformation syndromes in 27,472 newborns. Brain Dev (1990) 0.97
Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5'-UTR-binding nuclear factor and its implications in Alzheimer's disease. J Alzheimers Dis (2003) 0.96
Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology (Berl) (1996) 0.95
Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study. Brain Res (2000) 0.95
Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. IX. Its effect on the histology of the regional lymph node and other lymphoid organs. Microbiol Immunol (1980) 0.95
[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther (1997) 0.95
Regulation of the expression of proto-oncogene c-src by alternative RNA splicing in chicken skeletal muscle. Oncogene Res (1987) 0.95
Smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol (1971) 0.94
Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology (1995) 0.94
Radial maze performance in young and aged mice: neurochemical correlates. Pharmacol Biochem Behav (1985) 0.94
Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. Eur J Pharmacol (1993) 0.94
Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett (1985) 0.94
An alternative method of arterial reconstruction after hepatic arterial thrombosis following living-related liver transplantation. Transplantation (2000) 0.94
PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke (1996) 0.93
sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke (2000) 0.93
Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome. Am J Med (1992) 0.93
Distribution of S-100b protein in normal salivary glands and salivary gland tumors. Virchows Arch A Pathol Anat Histopathol (1983) 0.93
Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent. Endocrinology (2001) 0.92
Vitamin B12 treatment for sleep-wake rhythm disorders. Sleep (1990) 0.92
Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull (1994) 0.92
Effects of L-cocaine on local cerebral glucose utilization in the rat. Neurosci Lett (1986) 0.92
Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur J Pharmacol (1998) 0.91
Metastases from occult thyroid carcinoma. An autopsy study from Hiroshima and Nagasaki, Japan. Cancer (1970) 0.91
Differentiation and proliferation of primary rat hepatocytes cultured as spheroids. J Biochem (1998) 0.91
Growth characteristics in fed-batch culture of hybridoma cells with control of glucose and glutamine concentrations. Biotechnol Bioeng (1994) 0.91
Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Des (2004) 0.91
Cerebrovascular Biology and the various neural barriers: challenges and future directions. Neurosurgery (1999) 0.91
6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci (2000) 0.91
Effect of age and caloric restriction on cutaneous wound closure in rats and monkeys. J Gerontol A Biol Sci Med Sci (1997) 0.90
Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab (2009) 0.90
Aging and caloric restriction in nonhuman primates: behavioral and in vivo brain imaging studies. Ann N Y Acad Sci (2001) 0.90
In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci (1998) 0.90
Optimizing drug delivery to brain tumors. Cancer Treat Rev (1987) 0.90
Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res (1987) 0.90
Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Res (1992) 0.89